Clinical Data Wave crashes on obesity drug update; Kodiak’s reboot pays dividends BioPharma DiveWave s drug, which is meant to improve body composition, disappointed investors but was defended by analysts.Clinical DataMetabolic & GLP-1Read full story pharminent March 26, 2026 (Last updated: March 27, 2026) BioPharma Dive Wave s drug, which is meant to improve body composition, disappointed investors but was defended by analysts. Clinical DataMetabolic & GLP-1Read full story Post navigation Previous: Maze tumbles despite positive data for kidney disease drugNext: FDA clears Denali drug in ‘clear step’ for rare disease biotechs Related Stories Clinical Data Novo Nordisk starts trialing lower maintenance doses of oral Wegovy pharminent August 21, 2026 Clinical Data Cancer vaccine win restores Wall Street’s faith in Moderna pharminent August 20, 2026 Clinical Data New Taiho, Cullian data heats up lung cancer drug battle pharminent August 13, 2026
